EGFR inhibition down-regulates MGMT and enhances responsiveness to temozolomide in glioblastoma. - Nayab A; Mughal N; Angez M; Xing S; Burma AM; Balla H; Kizilbash SH; Yang X; Maqbool MA; Arain F; Hussain A; Amir S; et al. (Science translational medicine, 2026)